Iain Ross

Iain Ross

Chief Executive Officer at SILENCE THERAPEUTICS PLC

Net worth: 166 914 $ as of 31/05/2026

72 year
Health Technology
Commercial Services
Consumer Services

Profile

Iain Gladstone Ross founded Biomer Technology Ltd. in 2003, where he is working as Director from 2003.
Mr. Ross also currently works at Silence Therapeutics Plc, as Chairman & Chief Executive Officer from 2025, ReNeuron Group Plc, as Executive Chairman from 2023, Novagen Ltd., as Chairman, and various other companies.
Mr. Ross also formerly worked at LNRS Data Services Ltd. (Surrey), as Chief Executive Officer, Sandoz AG, as Chairman & Chief Executive Officer, Lonza Biologics Plc, as Chief Executive Officer, and various other companies.
Mr. Ross received his undergraduate degree from the University of London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/03/2026 39,942 ( 0.03% ) 71 896 $ 30/11/2025
10/11/2025 23,333,333 ( 0.54% ) 58 100 $ 31/05/2026
21/04/2026 2,107,209 ( 0.25% ) 36 918 $ 31/05/2026

Iain Ross active positions

CompaniesPositionStart
SILENCE THERAPEUTICS PLC Chief Executive Officer 14/12/2025
RENEURON GROUP PLC Chairman 01/07/2021
TERN PLC Director/Board Member 29/10/2024
OXFORD BIODYNAMICS PLC Chairman 31/01/2025
Chairman -
Founder 01/01/2003
Gladstone Partners Ltd.
Director/Board Member -

Former positions of Iain Ross

CompaniesPositionEnd
ADALTA LIMITED Director/Board Member 30/06/2025
BIVICTRIX THERAPEUTICS PLC Chairman 06/01/2023
░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Iain Ross's experience

Training of Iain Ross

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

44

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies44

Health Technology

Health Technology

Health Technology

Non-Energy Minerals

Technology Services

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Consumer Services

Producer Manufacturing

Consumer Services

Process Industries

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Gladstone Partners Ltd.

Tissue Therapies Europe Ltd.

Yellowcross Ltd.

Health Technology

Health Technology

Consumer Services

Process Industries

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!